NIS to examine disease activity in SLE patients treated with subcutaneous anifrolumab in routine care

Trial Identifier:	D3461R00100
Sponsor:	AstraZeneca
Collaborator:	None
Start Date:	March 2026
Primary Completion Date:	August 2029
Study Completion Date:	August 2029
Condition:	Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.